Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-08-23 | Kiromic Biopharma, Inc. | BERSANI PIETRO
(Chief Executive Officer) |
P | Common Stock | A | 3488 | $1.93 - $2.20 | $7,406 |
| 2024-06-12 | Kiromic Biopharma, Inc. | Misajon Pamela
(Director) |
P | Common Stock | A | 1610 | $3.24 - $3.30 | $5,288 |
| 2024-06-11 | Kiromic Biopharma, Inc. | NAGEL MICHAEL
(Director) |
P | Common Stock | A | 1000 | $3.33 - $3.33 | $3,330 |
| 2024-06-10 | Kiromic Biopharma, Inc. | Misajon Pamela
(Director) |
P | Common Stock | A | 1701 | $2.93 - $2.93 | $4,983 |
| 2024-06-12 | Kiromic Biopharma, Inc. | Hungerford Brian
(CFO) |
P | Common Stock | A | 1000 | $3.18 - $3.18 | $3,180 |
| 2024-06-11 | Kiromic Biopharma, Inc. | BERSANI PIETRO
(CEO) |
P | Common Stock | A | 6000 | $3.23 - $3.28 | $19,530 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |